. or water. symptoms include fatigue, low appetite, stomach pain, nausea, and jaundice.
.
.
.
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
a sign at a planned parenthood clinic is pictured in oklahoma city, in 2015.
.
.